Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 3 spellings of its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Ascend Therapeutics US, LLC with 1 drug recall, 1 drug application and 1 OPDP letter. The most recent is an OPDP letter dated Aug 16, 2018: Untitled letter: EstroGel.
| Aug 16, 2018 | Untitled letter: EstroGelOffice of Prescription Drug Promotion | OPDP letters |
| Nov 19, 2012 | EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physician starter samples; product is lClass III · Defective Container: Pump head detaching from the canister unit upon removal of the overcap. | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
